FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

21198611000001103: Xeplion 150mg/1.5ml and 100mg/1ml suspension for injection treatment initiation pack (Janssen-Cilag Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Sep 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
70559601000001110 Xeplion 150mg/1.5ml and 100mg/1ml suspension for injection treatment initiation pack (Janssen-Cilag Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70559701000001117 Xeplion 150mg/1.5ml and 100mg/1ml suspension for injection treatment initiation pack (Janssen-Cilag Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xeplion 150mg/1.5ml and 100mg/1ml suspension for injection treatment initiation pack (Janssen-Cilag Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xeplion 150mg/1.5ml and 100mg/1ml suspension for injection treatment initiation pack (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xeplion 150mg/1.5ml and 100mg/1ml suspension for injection treatment initiation pack (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Xeplion 150mg/1.5ml and 100mg/1ml suspension for injection treatment initiation pack (Janssen-Cilag Ltd) Is a Paliperidone 150mg/1.5ml suspension for injection pre-filled syringes and Paliperidone 100mg/1ml suspension for injection pre-filled syringes true Inferred relationship Existential restriction modifier
Xeplion 150mg/1.5ml and 100mg/1ml suspension for injection treatment initiation pack (Janssen-Cilag Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xeplion 150mg/1.5ml and 100mg/1ml suspension for injection treatment initiation pack (Janssen-Cilag Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Xeplion 150mg/1.5ml and 100mg/1ml suspension for injection treatment initiation pack (Janssen-Cilag Ltd) Has dispensed dose form Dose form not applicable (qualifier value) true Inferred relationship Existential restriction modifier
Xeplion 150mg/1.5ml and 100mg/1ml suspension for injection treatment initiation pack (Janssen-Cilag Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Xeplion 150mg/1.5ml and 100mg/1ml suspension for injection treatment initiation pack (Janssen-Cilag Ltd) Is a Xeplion true Inferred relationship Existential restriction modifier
Xeplion 150mg/1.5ml and 100mg/1ml suspension for injection treatment initiation pack (Janssen-Cilag Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Xeplion 150mg/1.5ml and 100mg/1ml suspension for injection treatment initiation pack (Janssen-Cilag Ltd) Has active ingredient Paliperidone true Inferred relationship Existential restriction modifier
Xeplion 150mg/1.5ml and 100mg/1ml suspension for injection treatment initiation pack (Janssen-Cilag Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Xeplion 150mg/1.5ml and 100mg/1ml suspension for injection treatment initiation pack (Janssen-Cilag Ltd) Has manufactured dose form Dose form not applicable (qualifier value) false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Xeplion 150mg/1.5ml and 100mg/1ml suspension for injection treatment initiation pack (Janssen-Cilag Ltd) 2 pre-filled disposable injection 1 x (1 inj + 1 inj) Has AMP True Xeplion 150mg/1.5ml and 100mg/1ml suspension for injection treatment initiation pack (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start